BIOMED-logo
Biomed treatments
ALS patient

NA-704 to treat Amyotrophic Lateral Sclerosis (ALS)

patient nurse

NA-831 to treat Alzheimer’s disease

depression

NA-901 to treat major depression

stroke patient

NA-911 to treat major depression

Rett Syndrom

NA-921 (Bionetide) to treat Rett Syndrome

fat man

NA-931 to treat Diabetes Obesity

fat man

NA-941 to treat Liver Diseases (MASH)

Biomed AI

Biomed AI

PRODUCT PIPELINE

Biomed has developed a family of patented drugs for the treatment of ALS, Alzheimer’s disease, major depressive disorder, diabetes obesity and rare diseases including Rett Syndrome and Fragile X.

NA-704: for the treatment and prevention Amyotrophic Lateral Sclerosis (ALS) (Phase 2B)

NA-831: for the treatment and prevention of Mild and Moderate Alzheimer’s Disease (Phase 2B/3)

NA-901: for the treatment of Major Depressive Disorder (Phase 2B/3)

NA-911: for the treatment of Stroke (Phase 2A)

NA-921 (Bionetide): for the treatment of Rett Syndrome and Fragile X (Phase 2B/3)

NA-931: for the treatment of Diabetes Obesity (Phase 2B/3)

NA-941: for the treatment of Metabolic dysfunction-associated steatohepatitis (MASH) (Phase 2A)

MICROS: MICROS Infusion System (Approved by the FDA)

pipeline

For further information about our products, please contact us by completing an Online Contact Form.
Thank you.

Learn more

Quick Links

  • Home
  • Alzheimer’s Drugs
  • Major Depression
  • Diabetes Obesity

Quick Links

  • About
  • Rett Syndrome
  • Biomed AI
  • Contact

Follow Us

Contact

Biomed Industries, Inc.
2570 N. First Street, 2nd Floor
San Jose, CA 95131, USA

Tel. 1-800-824-5135
Email: info@biomedind.com
Web site: www.biomedind.com

  • Terms of Use
  • Privacy Policy
  • © 2024 Biomed Industries, Inc.™
  • All Rights Reserved